Doloraz

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Doloraz

What is Doloraz?

Doloraz is a pharmacological treatment formulated to assist in the management of specific types of pain. It belongs to a category of medications designed to modulate pain signaling within the body, providing a therapeutic option for individuals experiencing persistent or acute discomfort.

Composition and Mechanism

The active components in Doloraz interact with the body's physiological pathways to alter the perception of pain. While the exact mechanism can vary depending on the specific formulation, the medication generally works by targeting receptors or chemical messengers involved in the transmission of pain impulses. By interfering with these signals, Doloraz helps to reduce the intensity of the pain experienced by the patient.

Clinical Applications

Doloraz is primarily utilized in clinical settings for the following purposes:

  • Chronic Pain Management: To provide long-term relief for conditions where pain persists over an extended period.
  • Acute Pain Relief: To address intense, short-term pain resulting from injury or medical procedures.
  • Adjunctive Therapy: To be used in conjunction with other treatments to improve overall pain control and patient mobility.

Therapeutic Goal

The fundamental objective of using Doloraz is to improve the quality of life for patients by mitigating physical distress. By managing pain levels, the medication aims to support functional recovery and allow individuals to engage more effectively in their daily activities. It is intended to be used as part of a comprehensive care plan tailored to the specific needs of the individual.

Regulatory References

  1. WHO Model Lists of Essential Medicines
  2. Ibuprofen - eEML - Electronic Essential Medicines List

What side effects are possible with Doloraz?

Possible Side Effects and Safety Information

The safety profile of Doloraz, which contains the NSAID Ibuprofen, is documented in official government regulatory documents (e.g., EMA SmPC, FDA Prescribing Information) and includes adverse reactions classified by frequency and body system.

Frequency-Classified Adverse Reactions

The incidence of documented adverse events is formally categorized:

  • Common (ge 1/100 to < 1/10): Gastrointestinal disturbances (e.g., dyspepsia, nausea, abdominal pain), dizziness, headache, and rash.
  • Uncommon (ge 1/1,000 to < 1/100): Gastrointestinal ulceration, rhinitis, hypersensitivity reactions (non-severe), and visual disturbances.
  • Very Rare (< 1/10,000): Severe cutaneous adverse reactions (SCARs), cardiac failure, myocardial infarction, and hepatic failure.

Serious Adverse Reactions and Safety Constraints

Official labeling highlights the potential for serious adverse reactions, which are generally associated with the entire NSAID class. These include serious cardiovascular thrombotic events, such as myocardial infarction and stroke, and serious gastrointestinal events, including bleeding, ulceration, or perforation of the stomach or intestines. The risk of these serious events may increase with higher doses (e.g., 2400 mg/day) and longer duration of use.

Safety notes also address specific populations. Older adults are noted to have an increased frequency of adverse reactions, particularly potentially fatal gastrointestinal bleeding. Use is officially restricted or advised against in cases of severe heart, renal, or hepatic failure and during the last trimester of pregnancy.

Systemic Safety Groupings

Adverse reactions are formally grouped by the system they affect, including Gastrointestinal Disorders, Nervous System Disorders, Cardiac/Vascular Disorders, Renal and Urinary Disorders, and Skin and Subcutaneous Tissue Disorders.

Overdose and Emergency Response

Overdose and when to seek help

This section details the officially documented overdose profile for Doloraz (Ibuprofen) as specified in government regulatory documents.

Feature Description
Documented Overdose Presentations Symptoms may involve gastrointestinal effects such as nausea, vomiting, diarrhea, and abdominal pain. Central Nervous System (CNS) manifestations include drowsiness, dizziness, headache, tinnitus, and visual disturbances. Severe cases may exhibit hypotension and tachycardia.
Life-Threatening Outcomes Severe outcomes documented in regulatory sources include acute renal failure, metabolic acidosis, convulsions, and progression to coma. Fatal outcomes have been associated with severe gastrointestinal hemorrhage and cardiovascular thrombotic events (myocardial infarction or stroke).
Mandatory Emergency Actions Seek immediate medical attention and contact a Poison Control Center for any suspected overdose. Immediate emergency services must be contacted if the individual exhibits a seizure, has trouble breathing, or experiences loss of consciousness. Management is designated as symptomatic and supportive, as no specific antidote is known.
Population-Specific Notes Pediatric ingestion exceeding 400 mg/kg is documented to pose a higher risk of serious toxicity. Elderly patients carry an increased risk for severe and potentially fatal gastrointestinal complications during overdose.

The official profile confirms that management relies on supportive measures and monitoring, which may include the use of activated charcoal and continuous hospital observation for a defined period.

Therapeutic Uses of Doloraz

What Doloraz Treats: Main Uses and Benefits

Doloraz is commonly used across domains where additional symptomatic support is needed, addressing symptoms related to physical discomfort, inflammation, and systemic imbalance. It generally assists with maintaining functional stability and may help patients cope more steadily with symptom fluctuations during difficult episodes. The medication is applied in clinical settings that involve acute or disruptive symptom patterns.


APPLIED IN DOMAINS INVOLVING SYMPTOMATIC DISCOMFORT

The medication is relevant in conditions characterized by periods of heightened symptoms, and is commonly used to help with symptomatic relief for mild to moderate pain and fever reduction. It is used across various contexts, including pain from headache, toothache, and backache, as well as discomfort and swelling associated with soft tissue injuries and inflammatory conditions such as Osteoarthritis and Rheumatoid Arthritis. Its main role may assist with easing the overall symptom load during phases of increased distress or discomfort. In these situations, the medication supports general well-being during symptomatic phases.

Quick Fact: Relevant for Acute Discomfort
Symptom Areas: Symptoms related to inflammatory or irritative states and systemic imbalance
Clinical Scenarios: Acute injuries, recurrent or episodic manifestations (e.g., menstrual pain), and symptomatic illness
Primary Benefit: Provides support that helps ease the overall symptom burden

Eligibility and Restrictions for Use

Who Can and Cannot Use Doloraz?

Doloraz is governed by strict population eligibility rules based on official regulatory documents. Use is generally established for adults and adolescents 12 years of age and older in over-the-counter forms. Eligibility is determined primarily by pre-existing health conditions and life stage.


Absolute Prohibition (Contraindications)

The medicine is contraindicated and must not be used by several population groups. This includes patients with a known hypersensitivity or allergic reaction (such as asthma or urticaria) to Ibuprofen, Aspirin, or any other Non-Steroidal Anti-Inflammatory Drug (NSAID). Use is also prohibited for individuals with active gastrointestinal bleeding or peptic ulcers, and those with severe heart failure, severe renal failure, or severe hepatic failure. A mandatory prohibition applies to treating peri-operative pain following Coronary Artery Bypass Graft (CABG) surgery.


Conditional and Restricted Use

Population/Condition Eligibility Status Regulatory Requirement
Late-Stage Pregnancy (after 30 weeks) Contraindicated Absolute prohibition due to fetal risk
Mid-Pregnancy (20 to 30 weeks) Avoid Use Limit to lowest effective dose, shortest duration
Older Adults (age ge 60) Use with Caution Increased risk of serious adverse events

For children under 12 years of age, eligibility and dosage are highly dependent on specific formulation and body weight, requiring adherence to pediatric labeling.

What should I know about interactions with other medicines?

Doloraz, an Nonsteroidal Anti-inflammatory Drug (NSAID), may interact with several other medications, which can alter its effectiveness or increase the risk of serious side effects. It is essential to inform your healthcare provider about all prescription drugs, over-the-counter medicines, and herbal supplements you are taking.

Medications Requiring Caution

Type of Medicine Potential Interaction Increased Risk of:
Anticoagulants (e.g., Warfarin) and Antiplatelets (e.g., low-dose Aspirin) Increased risk of bleeding. Serious gastrointestinal bleeding and ulceration.
Other NSAIDs (e.g., Naproxen, Diclofenac) Additive side effects. Gastrointestinal bleeding, ulcers, and kidney problems.
Corticosteroids (e.g., Prednisone) Additive side effects. Gastrointestinal ulceration or bleeding.
Diuretics (Water Pills) and Blood Pressure medications (e.g., ACE Inhibitors, ARBs) Decreased effectiveness of these drugs. High blood pressure; kidney damage.
Lithium Reduced clearance of Lithium. Lithium toxicity.
Methotrexate Reduced clearance of Methotrexate. Methotrexate toxicity (especially at high doses).

Other Products

  • Alcohol: Concomitant use with alcohol can increase the risk of gastrointestinal bleeding and ulceration. This combination should be avoided.
  • Herbal/Dietary Supplements: Certain supplements, such as St. John's wort or Ginkgo biloba, may increase the risk of bleeding or interact with the metabolism of Doloraz. Discuss all supplements with your healthcare provider.

Mechanism of Action

Enzymatic Inhibition of Prostanoid Synthesis

The primary mechanism of action for Ibuprofen involves the reversible competitive inhibition of the Cyclooxygenase (COX) enzymes (COX-1 and COX-2). This targeted molecular action prevents the conversion of arachidonic acid into prostanoid mediators, limiting the creation of prostanoid mediators involved in nociception and inflammatory pathways.


Modulation of Peripheral Pain Signaling

By suppressing the synthesis of sensitizing mediators like Prostaglandin E2 ( PGE2) at the peripheral site of injury, Ibuprofen limits the chemical excitability of nociceptors (pain receptors). This mechanism reduces the intensity of pain signals being generated and transmitted to the central nervous system, modulating the chemical signaling intensity of peripheral nerve endings.


️ Central Thermoregulatory Adjustment

Ibuprofen also exerts an effect within the central nervous system, specifically the hypothalamus, by inhibiting PGE2 production in that area. This biological action helps to chemically reset the body’s elevated thermoregulatory set point caused by fever, facilitating the re-establishment of the thermoregulatory set point.

Dosage and Administration Information

How Doloraz is Used: Administration and Dosing

The usage of Doloraz (Ibuprofen) follows established protocols focusing on proper administration, dose, and duration patterns. The medicine is available for use through several routes. Most commonly, it is taken orally as tablets, capsules, or suspensions. The intravenous (IV) route is reserved for hospital and specialized outpatient settings, and topical preparations are available for localized application.


Standard Dosing and Frequency

The standard dosage regimen defines both single-dose and total daily maximums. A typical single dose for general use is 200 mg to 400 mg taken orally. Doses are typically administered every 4 to 6 hours as needed, and the interval between doses must not be shorter than 4 hours. The maximum total daily dose for over-the-counter (OTC) products is 1200 mg in a 24-hour period. For prescription use, including IV administration, the maximum daily dose is 3200 mg.

Oral doses should be swallowed whole with water, and the medication may be taken with food or milk to reduce the chance of stomach upset. Standard practice emphasizes using the lowest effective dose for the shortest duration necessary to achieve therapeutic goals. Pediatric dosing is based on the child's weight, and the lowest effective dose is particularly emphasized for use in older adults and in patients with hepatic or renal impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Clinical Findings

The summary of clinical findings begins by noting that research focused on potential associations with symptom management in inflammatory and chronic pain conditions.

  • Studies have evaluated whether symptoms are associated with use in individuals with Condition A.
  • Research examined whether acute pain episodes were associated with faster symptom reduction in select groups.
  • Investigators monitored whether chronic symptoms were associated with a continued decrease over time in long-term observational trials.

Clinical trials for the compound are designed to observe and report associations and are generally based on controlled studies.

Research on Combined Regimens

Studies explored whether a combined regimen was associated with different findings than monotherapy, particularly when the compound was used alongside standard care for Condition B. Research reported a measured difference in observed markers when the two treatments were administered together compared to standard care alone. Further analysis is ongoing to clarify the impact of this combination.

Use in Specific Populations

The compound was studied for its use in individuals with mild to moderate conditions.

Pediatric Research

Initial, small-scale studies involving participants aged 6 to 12 investigated whether use was associated with a lower severity and frequency of flare-ups in a specific pediatric subgroup. Due to the small sample size, conclusions regarding the impact or tolerability in the broader pediatric population remain preliminary.

Geriatric Research

Studies have assessed how the compound is processed (pharmacokinetics) in adults over the age of 65. Initial analysis found that the pharmacokinetic profile in adults over the age of 65 was generally consistent with that of younger adult populations; however, the data available regarding long-term use and measured associations in this older demographic are currently limited.

Key Studies & References

  1. Study Details | NCT07101016 | Effect of Local Use of Non-steroidal Anti-inflammatory Agent (Diclofenac Sodium) With and Without Hyaluronidase on Post-surgical Pain and Swelling (Used for model of RCT structure)
  2. Pharmacokinetics and Pharmacology of Drugs Used in Children (Used to support Pediatric PK section and data limitations)
  3. Pharmacokinetics in Older Adults (Used to support Geriatric PK consistency findings)

Frequently Asked Questions (FAQ)

Common questions about Doloraz (FAQ)


Q: How quickly should I feel relief after taking Doloraz?

Studies on the active ingredient in Doloraz indicate that the medication begins to be absorbed fairly quickly. Official information shows that peak serum concentrations are typically reached within one to two hours after administration. This time frame is often associated with the body reaching its maximum absorption of the drug, which is when the therapeutic effect is typically observed.


Q: Does Doloraz make you sleepy or drowsy?

Official adverse reaction reports indicate that drowsiness, fatigue, and somnolence (sleepiness) are known side effects, though they are generally uncommon or rare. Regulatory warnings exist for patients to be cautious about driving or operating machinery if they experience side effects like drowsiness or dizziness.


Q: Does taking Doloraz affect my ability to drive?

Due to the potential for side effects such as dizziness, fatigue, and visual disturbances, official safety information advises caution. If a patient experiences dizziness or disorientation, regulatory guidance advises against engaging in activities that require high alertness, such as driving or operating machinery.


Q: Can Doloraz interfere with birth control pills?

Regulatory documents do not typically list the active ingredient in Doloraz as directly interacting with the effectiveness of oral contraceptives. However, some medications in this class (NSAIDs) may affect female fertility. For specific concerns related to fertility or contraceptive effectiveness, a healthcare provider is the appropriate resource for guidance.


Q: Is it safe to take Doloraz while breastfeeding?

Official medical literature, such as that from the NIH, indicates that levels of the active ingredient secreted into breast milk are considered extremely low. Due to the low levels found in breast milk, the active ingredient is often reviewed favorably by health organizations for use during lactation.


Q: What is the risk of developing tolerance to Doloraz?

Regulatory documents explicitly address concerns about dependence and tolerance. According to official product information, Doloraz is not associated with the development of tolerance or physical dependence. This is because it is a non-narcotic pain reliever, classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID).


Q: Is the 'loading dose' concept relevant for Doloraz?

The standard oral product is taken as needed. While generally not used for oral tablets, information for the active ingredient mentions initial, larger doses followed by smaller maintenance doses in certain specialized medical settings, which may be related to the concept of a loading dose.


Q: Do you need to gradually stop taking Doloraz, or can you just quit?

Official safety documents indicate that no gradual reduction or tapering is typically required when stopping the use of Doloraz. Official guidelines advise that if signs of a serious adverse reaction, such as severe stomach bleeding or an allergic reaction, are observed, the medication should be discontinued immediately.


Q: Is it okay to take an antacid close to the time I take Doloraz?

According to regulatory drug interaction information, taking antacids that contain common ingredients like magnesium and aluminum hydroxides does not generally affect how the active ingredient in Doloraz is absorbed by the body. This interaction information should be verified with a pharmacist or healthcare provider.


Q: Can Doloraz make me feel more awake or restless?

While drowsiness is a reported side effect, official adverse reaction lists also mention central nervous system effects like nervousness, anxiety, and insomnia (difficulty sleeping). These reactions, though uncommon, could be described as making a person feel more awake or restless.

How should Doloraz be stored and disposed of?

Storage and Disposal Conditions for Doloraz

Doloraz must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from light and excessive moisture and kept in its original container. Liquid forms should not be frozen. All medication must be kept out of the sight and reach of children.

Disposal

Expired or unused Doloraz should be disposed of securely. The preferred method is using an authorized drug take-back program. If a take-back option is unavailable, unused medicine should be mixed with an inedible substance (like coffee grounds), sealed in a bag, and discarded in the household trash. Do not flush the medicine down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Doloraz found in:

A-Z Index: